Topics › Health Sciences › Medicine › Hematology
Multiple Myeloma Research and Treatments Sign in to save
Papers per year
Papers 158
Open in paper search →-
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma2023 New England Journal of Medicine article Medicine Multiple Myeloma Research and Treatments Open access cited by 1 patent
Pieter Sonneveld, Meletios Athanasios Dimopoulos, Mario Boccadoro, Hang Quach, P. Joy Ho, Meral Beksaç, +37 more
588citations -
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study2020 The Lancet Haematology article Medicine Multiple Myeloma Research and Treatments Open access cited by 2 patents
Michèle Cavo, Francesca Gay, Meral Beksaç, Lucia Pantani, Maria Teresa Petrucci, Meletios Athanasios Dimopoulos, +54 more
384citations -
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial
Thierry T.F. Facon, Shaji Kunnathu Kumar, Torben Plesner, Robert Zygmunt Orlowski, Philippe Moreau, Nizar Jacques Bahlis, +23 more
376citations -
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial2021 The Lancet Oncology article Medicine Multiple Myeloma Research and Treatments Open access cited by 13 patents
Meletios Athanasios Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksaç, Eirini Katodritou, +58 more
345citations -
The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape2021 Nature Immunology article Medicine Multiple Myeloma Research and Treatments Open access cited by 2 patents
Madelon M.E. de Jong, Zoltán Kellermayer, Natalie Papazian, Sabrin Tahri, Davine Hofste op Bruinink, Remco Michiel Hoogenboezem, +9 more
255citations -
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial
Philippe Moreau, Cyrille Hulin, Aurore Perrot, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, +46 more
182citations -
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial
Hartmut Goldschmidt, Uta Bertsch, Roland R. Fenk, Eva Nievergall, Diana Tichy, Britta Besemer, +26 more
160citations -
Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial
Philippe Moreau, Cyrille Hulin, Aurore Perrot, Bertrand Arnulf, Karim Belhadj, Lotfi Benboubker, +44 more
130citations -
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial2024 Journal of Clinical Oncology article Medicine Multiple Myeloma Research and Treatments Open access
Elias Karl Mai, Uta Bertsch, Ema Požek, Roland R. Fenk, Britta Besemer, Christine Hanoun, +71 more
80citations -
Talquetamab (tal) + daratumumab (dara) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Updated TRIMM-2 results.2023 Journal of Clinical Oncology conference-abstract Medicine Multiple Myeloma Research and Treatments Open access
Bhagirathbhai Dholaria, Katja Christina Weisel, María‐Victoria Mateos, Hartmut Goldschmidt, Thomas G. Martin, Daniel Morillo, +14 more
66citations -
The IKZF1–IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages2021 Cancer Immunology Research article Medicine Multiple Myeloma Research and Treatments Open access
Dimitrios Mougiakakos, Christian Bach, Martin Böttcher, Fabian Beier, Linda Röhner, Andrej Stoll, +18 more
54citations -
Stem cell yield and transplantation in transplant-eligible newly diagnosed multiple myeloma patients receiving daratumumab + bortezomib/thalidomide/dexamethasone in the phase 3 CASSIOPEIA study
Cyrille Hulin, Fritz C. Offner, Philippe Moreau, Murielle Roussel, Karim Belhadj, Lotfi Benboubker, +17 more
54citations -
Apollo: Phase 3 Randomized Study of Subcutaneous Daratumumab Plus Pomalidomide and Dexamethasone (D-Pd) Versus Pomalidomide and Dexamethasone (Pd) Alone in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
Meletios Athanasios Dimopoulos, Evangelos Terpos, Mario Boccadoro, Sosana Delimpasi, Meral Beksaç, Eirini Katodritou, +17 more
51citations -
Efficacy and Safety of Less Frequent/Lower Intensity Dosing of Talquetamab in Patients with Relapsed/Refractory Multiple Myeloma: Results from the Phase 1/2 MonumenTAL-1 Study
Ajai Chari, Albert Oriol, Amrita Y. Krishnan, Maria Del Carmen Martinez Chamorro, Luciano J. Costa, María‐Victoria Mateos, +9 more
50citations -
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab2024 Clinical Lymphoma Myeloma & Leukemia article Medicine Multiple Myeloma Research and Treatments Open access
Ajai Chari, Amrita Y. Krishnan, Leo Rasche, Jing Christine Ye, Alfred L. Garfall, Rakesh Popat, +13 more
49citations -
Phase 2 Study of Teclistamab-Based Induction Regimens in Patients with Transplant-Eligible (TE) Newly Diagnosed Multiple Myeloma (NDMM): Results from the GMMG-HD10/DSMM-XX (MajesTEC-5) Trial
Marc Steffen Raab, Niels Weinhold, Klaus Martin Kortüm, Jan Krönke, Lilli Podola, Uta Bertsch, +23 more
47citations
Most active Aachen authors
-
Linda Köster 1,844 citations overall30 papers
-
JESSICA T. VERMEULEN 10,466 citations overall27 papers
-
Tobias Kampfenkel 2,158 citations overall18 papers
-
Luuk A. Gras 5,079 citations overall15 papers
-
Deniz Gezer 1,428 citations overall15 papers
-
Carla de Boer 3,016 citations overall11 papers
-
Brenda J. Tromp 1,737 citations overall11 papers
-
Liesbeth C. de Wreede 4,718 citations overall9 papers
-
Laurien G.A. Baaij 115 citations overall8 papers
-
M. Damiette Smit 158 citations overall7 papers
-
Emilie M.J. van Brummelen 4,842 citations overall6 papers
-
Carla J. de Boer 2,995 citations overall6 papers
-
Dirk‐Jan Eikema 1,017 citations overall5 papers
-
Peter A. von dem Borne 4,245 citations overall4 papers
-
Martina Margrit Crysandt 2,348 citations overall4 papers